Mild cognitive impairment, MCI
Conditions
Interventions
Group 1: Integrated Intervention Group (Body + Mind + Social) :Receives the full "Lighting System" intervention.
Core intervention group. Tests whether the full "whole-person-environment" perspective
Group 2: Whole-Person Group (Body + Mind) :Receives physical exercise from the "Body System" plus training in "Cognitive Training Games."
Core control group. Key comparison with Group 1 to isolat
Group 3: Single Environmental Group (Social Only) :Receives only group activities involving "social interaction."
Tests the independent effect of pure "environmental" intervention (social modality
Group 4: Active Control Group :Receives a non-specific intervention, such as simple electronic games (card games, puzzles), health lectures, etc. Shared baseline with the first three groups.
Sponsors
School of Social Development, East China Normal University
Eligibility
Sex/Gender
All
Age
55 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age between 55 and 75 years; 2. Subjective cognitive decline (SCD-Q positive) reported by the participant or an informed source; 3. Typically scores below 3 on the AD8; 4. Owns and can operate a smartphone (Android or iOS) with basic proficiency; 5. Sufficient vision, hearing (corrective devices permitted), and language ability to complete tests and interventions; 6. Voluntarily participates with full understanding of the study, and provides signed written informed consent by the subject and/or family member.
Exclusion criteria
Exclusion criteria: 1. Diagnosed dementia (Clinical Dementia Rating [CDR] >= 1, Mini-Mental State Examination [MMSE] < 17, or Montreal Cognitive Assessment [MoCA] < 18); 2. Other severe neurological disorders significantly impairing cognition (e.g., Parkinson's disease, severe post-stroke cognitive impairment, traumatic brain injury); 3. Severe uncontrolled psychiatric disorders (major depressive disorder, schizophrenia, bipolar disorder); 4. Severe visual, auditory, or motor impairments preventing completion of interventions and assessments; 5. Recent participation (within 3 months) in other cognitive intervention or drug clinical trials; 6. Long-term use of medications significantly affecting cognitive function (e.g., high-dose sedatives) that cannot be stabilized during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MOCA(Montreal Cognitive Assessment) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| QOL-AD(Quality of Life-Alzheimer’s Disease) Score;Lubben Social Network Scale Brief( LSNS-6 ) Score; | — |
Countries
China
Contacts
Public ContactChenxi Huang
School of Social Development, East China Normal University
Outcome results
None listed